Spectral AI Inc (NASDAQ:MDAI) has announced the appointment of Erich Spangenberg, the company’s largest shareholder, to its board of directors, who will serve as Executive Committee chairman as well as on the Nominating and Corporate Governance Committee.
The predictive AI company focused on medical diagnostics said Spangenberg has 40 years of experience as an entrepreneur, investor, investment banker, and attorney, as is the founder and managing director of Sauvegarder Investment Management, a multi-strategy investment firm dedicated to IP-related financings.
"We are enthusiastic about Erich's new role as Chairman of the Executive Committee of the Board of Directors, foreseeing his significant impact in advancing our mission to delivering improved care through our AI-driven predictive healing assessment technology," Spectral AI non-executive chairman Richard Cotton said in a statement.
Spangenberg also commented, stating: "My objective is to ensure that the company's valuation accurately mirrors the noteworthy accomplishments of our team, particularly the validation evidenced by Spectral AI's receipt of $251 million in non-dilutive funding from the US Government, along with our well-defined near and long-term prospects."
Based in Dallas, Spectral AI is focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers.
Contact Sean at sean@proactiveinvestors.com